Financial intermediary
CD3 IV (Centre for Drug Design and Discovery)
- Capital type
- Equity
- Provider
- EIF
- Country
- Belgium
- Target
- Research spin-outDeepTech
About
CD3 IV (Centre for Drug Design and Discovery) - EIF-backed equity intermediary under EIF Enabling sectors KU Leuven Research & Development Leuven Life science and health. Commitment: EUR 35,000,000.
Eligible geographies
- Belgium
Programmes
- EIF Enabling sectors
Capital stack
- equity
Next
Most finance matches are advisory — we map eligibility, intermediaries, and related calls before you leave for an official portal.